Evidence map›Paper›PMID 39282094›Full record

ArticleBiochemistry and biophysics reports2024

Elena Marino, Cristian Mauro, Elena Belloni, Marco Picozzi, Valentina Favalli, Maria Cristina Cassatella, Laura Zorzino, Luciano Giacò, Pier Giuseppe Pelicci, Massimo Barberis and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biochemistry and biophysics reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Elena MarinoClinic Unit of Oncogenomics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Cristian MauroLaboratory Medicine Division, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Elena BelloniDepartment of Experimental Oncology, Istituto Europeo di Oncogia, IRCCS, Milan, Italy.
Marco PicozziLaboratory Medicine Division, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Valentina Favalli4Basessrl, Pavia, Italy.
Maria Cristina CassatellaLaboratory Medicine Division, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Laura ZorzinoLaboratory Medicine Division, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Luciano GiacòBioinformatics Core Facility, Gemelli Science and Technology Park (G-STeP), Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Roma, Italy.
Pier Giuseppe PelicciDepartment of Experimental Oncology, Istituto Europeo di Oncogia, IRCCS, Milan, Italy.
Massimo BarberisClinic Unit of Oncogenomics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Maria Teresa SandriLaboratorio Bianalisi, Carate Brianza, MB, Italy.
Loris BernardClinic Unit of Oncogenomics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In metastatic breast cancer (MBC), blood is a source of circulating tumor cells (CTCs). CTCs may serve as a ''real-time liquid biopsy" as they represent metastatic tumor genetics better than primary tumor.

Indexed as

Circulating tumor cells(CTCs)Liquid biopsyNext generation sequencing(NGS)

Identifiers

PMID39282094
PMCPMC11396050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.